packageFulvestrant

fulvestrant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Fulvestrant is an estrogen receptor antagonist used to treat breast cancer. It is an approved medicine, authorised in the European Union for breast cancer.

Summary written by glm-5.3-flash from Wikidata Q5508491 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:fulvestrant
ATC codes:L02BA03
DrugBank:DB00947
PubChem CID:17756771
ChEBI:31638
Wikidata:Q5508491
formula:C32H47F5O3S
molar mass:606.775 g/mol (PubChem CID 17756771)
logP:9.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown